You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Besides the new InnoStamp arrayer, which relies on magnetic stamps to print arrays, the French company plans to launch an infrared version of its InnoScan 710 scanner.
The new office, based in Chicago, will mainly serve as a sales and marketing hub as Innopsys looks to grow its US customer base.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.